Seres Therapeutics Inc.

NASDAQ: MCRB
Share price (1/8/25): $0.85
Market cap (1/8/25): $145 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement

Shelf registration

Registration of securities for employees

Shelf registration

Registration of securities for employees

Ownership Filter

DesRosier Thomas

Von Moltke Lisa

Young Teresa L.

Henn Matthew R.

News Filter

Announces New Translational Biomarker Results From SER-155 Phase 1b Clinical Study and Provides Corporate Updates

Reports Third Quarter 2024 Financial Results and Provides Business Updates

Announces Completion of VOWST™ Asset Sale to Société Des Produits Nestlé S.A

Stockholders Approve Sale of Vowst™ to Nestlé Health Science; Sale Expected to Close on September 30

Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Proxies Filter

Additional info about upcoming vote

Proxy related to merger

Additional info about upcoming vote

Preliminary proxy related to merger

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC